Health ❯Healthcare ❯Clinical Trials
FDA Microbiology Pharmaceuticals Clinical Trials Medication Adherence Bacterial Infections Diabetes Investments Cancer Treatment Drug Competition
Amgen plans a 72-week pivotal study following phase 2 results that showed substantial weight loss alongside lower gastrointestinal side effects from a low-dose ramp-up.